Key points are not available for this paper at this time.
Background and Importance Hospital admissions of Parkinson's disease (PD) patients can result in medication regimen disruptions causing adverse effects for PD patients. Evidence shows that interventions can reduce medication-errors and administration of contraindicated medicines in PD patients. Aim and Objectives The study aim was to quantify the impact of a pharmacist's involvement in optimising medicines management of inpatient PD patients. Material and Methods A 2-month 'baseline' audit was completed prior to intervention implementation and measured patient demographics, delay in first dose following admission, medication errors (missed/delayed doses), pharmacist medicines reviews and time until completion and patient outcome (prevalence of falls, delirium, rigidity). The outcome of patients who were 'nil by mouth' was also assessed. Three interventions were implemented over a 1-month period. These were priority pharmacist medicines reviews of PD patients, PD medication ward stock optimisation and doctor/nurse PD medicine management education sessions. A post-intervention audit identical to the 'baseline' audit was completed and both audits were compared. Results The 'baseline' audit (mean age 81, 24 patients, 1,611 due doses) and the post-intervention audit (mean age 80, 30 patients, 1,840 due doses) were analysed. Medicine reviews increased from 79% to 97% (p=0.042) and these were completed 38.7 hours (pConclusion and Relevance This study showed the introduction of the pharmacist-led interventions can improve PD inpatient outcomes, by reducing medication errors, decreasing the administration of contraindicated medicines and preventing delays in the administration of PD drugs. References and/or Acknowledgements Conflict of Interest No conflict of interest.
Knipe et al. (Fri,) studied this question.